News
Investor's Business Daily on MSN1d
PTC Therapeutics Clears Key Benchmark, Hitting 80-Plus RS RatingHistory reveals that the top-performing stocks often have an RS Rating of at least 80 in the early stages of their moves. PTC Therapeutics broke out earlier, but has fallen back b ...
Investor's Business Daily on MSN5d
Arcutis Biotherapeutics Clears Key Benchmark, Hitting 80-Plus RS RatingArcutis Biotherapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback